NSTEMI Risk Prediction with the Combination of the Biomarkers Epicardial Adipose Tissue and Soluble Suppression of Tumorigenicity 2

Jiayu Yin; Bowen Qiu; Tingting Li; Yifei Tao; Xiaosong Gu

doi:10.12659/MSM.947019

10 March 2025 : Clinical Research

NSTEMI Risk Prediction with the Combination of the Biomarkers Epicardial Adipose Tissue and Soluble Suppression of Tumorigenicity 2

Jiayu Yin^1ACEFG, Bowen Qiu^2BCEF, Tingting Li^1CE, Yifei Tao^3ADE*, Xiaosong Gu^1AG

DOI: 10.12659/MSM.947019

Med Sci Monit 2025; 31:e947019

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 5 Kaplan-Meier survival curves for major adverse cardiac events (MACEs) during a year following non-ST-elevation myocardial infarction (NSTEMI) under and over cut-off values for (A) soluble suppression of tumorigenicity 2 (sST2), and (B) epicardial adipose tissue index (EATi). This figure was generated using GraphPad Prism 9, GraphPad Software, USA.

Back to the Article

NSTEMI Risk Prediction with the Combination of the Biomarkers Epicardial Adipose Tissue and Soluble Suppression of Tumorigenicity 2

Your Privacy